Vice President - Oncology Clinical Development, Disease Area Head- Hematology
WIB-Pittsburgh · Collegeville, PA · 3 wk ago
$341k–$568k/yrFull-time
About the role
GSK aims to impact the health of 2.5 billion people by the end of the decade through discovering and delivering vaccines and medicines, combining immune system understanding with cutting‑edge technology. The R&D culture is ambitious for patients, accountable for impact, and committed to doing the right thing. This role is based in GSK Collegeville, PA (on‑site) with a hybrid expectation of 2‑3 days per week in an office (Collegeville, PA or Waltham, MA; London or Stevenage (future Cambridge, UK); or Zug/Baar Onyx, Switzerland). The position reports to the SVP, Head of Oncology Clinical Development and serves as VP, Oncology Clinical Development Disease Area Head for the hematology portfolio.
Responsibilities
- Clinical Development Strategy & Portfolio Leadership: accountable for end‑to‑end clinical development of oncology assets from first‑in‑human through proof‑of‑concept, registrational trials, regulatory approval and initial market launch; shape and drive scientific and clinical development strategy aligned with Oncology Tumor Team strategy and broader portfolio priorities; integrate clinical and disease‑area expertise into preclinical and translational research to optimize asset positioning, biomarker strategy and development decisions; evaluate and enable novel approaches (AI/ML, innovative trial designs, real‑world data) where they add clear value.
- Program Oversight, Governance & Visibility: provide program‑level oversight and leadership, maintain cross‑functional and cross‑asset visibility of progress, risks, dependencies and trade‑offs; serve as senior clinical representative at key governance forums; represent Oncology Clinical Development internally and externally, including presenting at congress all‑hands, senior leadership reviews and advisory boards; lead scientific advisory boards and external engagements to inform asset strategy, competitive positioning and portfolio decisions.
- Cross‑Functional Leadership & Connector